CVS Health Corp | CVS | Long at $61.00NYSE:CVS Health Corp will need a revision to its business model in order to survive an ever-changing retail/pharmacy environment. However, with a P/E of 10x, debt-to-equity of less than 1x, growing cash flow, and dividend yield of 4.3%, the stock seems quite undervalued. Perhaps activist investors will soon step in, but if history repeats, there may be a nice bounce ahead as the price consolidates in the GETTEX:50S and low $60s. Thus, near its current price of $61, NYSE:CVS is in a personal buy zone.
Target #1 = $66.00
Target #2 = $68.00
Target #3 = $75.00
Target #4 = $79.00
Cvslong
Current Developments on CVS chart can make for opportunityHi guys! This is a Technical analysis on CVS Health Corporation (CVS) on the 3 day timeframe.
We discuss some Current developments on CVS, which maybe pointing to signs of potential opportunity to invest/ hold CVS.
We've had a deathcross that has brought us down more than 38%.
Which has lead us to a critical support trendline that has acted as support since March 2019.
We recently bounced from this trendline with a BULLISH ENGULFING candle print
We have from this support line bounced up to reach the 21 EMA
Current price action is attempting to establish support on 21 EMA.
MACD has crossed Bullish with Green bars printing.
BUT also remember that we have resistance above us from the 50 SMA.
We are also in an established DOWNTREND from the Deathcross. Until proven otherwise so we have to pay attention for signs of trend change.
Key area is around the 2 moving averages. We need to establish support on 21 EMA. We have to also see how we react with the 50 SMA. If we get ABOVE 50 SMA and maintain support, it is likely we print a GOLDEN CROSS, leading to BUY pressure to come in.
This could be the necessary catalyst for trend change.
Another hint in an attempt to trend change is the 21 EMA flattening out, beginning to show signs of a curvature to upside.
Now lets Look left to find evidence of previous patterns in the Moving average interactions, Support line interaction and MACD.
Our first time interacting with the SUpport line, we had many touches, before printing a GOLDEN CROSS. ALong with MACD CROSS ABOVE 0 level, we had a 48% Uptrend.
Our 2nd interaction with SUpport line, we experienced a fakeout on the 1st touch. MACD could NOT move ABOVE 0 level.
The 2nd touch of support line, had the GOLDEN CROSS and the MACD cross ABOVE 0 level. This lead to an extended Bull run for CVS with gains of 100%.
Keep this in mind. Look for similar pattern in our current price action. If we see a Golden Cross with MACD crossing ABOVE 0 level. This would mean an UPTREND is probable. But dont discount the possibility of a fakeout. We can always have another attempt to test support on support line.
Watch closely for these to develop in our current price action. Best opportunity to invest would be after Golden cross has been established with confirmed MACD cross Above 0 level in my opinion.
__________________________________________________________________________________
Thank you for taking the time to read my analysis. Hope it helped keep you informed. Please do support my ideas by boosting, following me and commenting. Thanks again.
Stay tuned for more updates on CVS in the near future.
If you have any questions, do reach out. Thank you again.
DISCLAIMER: This is not financial advice, i am not a financial advisor. The thoughts expressed in the posts are my opinion and for educational purposes. Do not use my ideas for the basis of your trading strategy, make sure to work out your own strategy and when trading always spend majority of your time on risk management strategy.
CVS is a good buyfor risk-takers this for you, CVS Health Corporation is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager and Aetna, a health insurance provider, among many other brands. The company's headquarters is in Woonsocket, Rhode Island.
By looking at the company file we got this
total assets
12/30/2020 12/30/2019 12/30/2018 12/30/2017
230,7 B 222,4B 196,4B 95,1B
Increasing percent from the year before.
3.73% in 2020 13.23 % in 2019 106.51% in 2018
The total debt
85,0B 89,0 B 73,4 B 27,0 B
percentage change from the year before
-4.49 % in 2020 +21.25 % in 2019 +171.85 % in 20218
---------------------------------------------
Debt percentage from assets
36.86% 40.01% 37.37% 28.39%
Net Income
7,57B 7,18 B 6,63 B -0.594 B 6,62 B
EBIT
12,64 B 12,67 B 12,03 B 4,02 B 9,33 B
Free cash flow
15,19 B 13,43 B 10,39 B 6,83 B 6,09 B
Return on Investment 5YA 4.12% for the company 6.44 for the sector
Return on Assets 5YA 3.06% for the company 5.83 for the sector
5 Year EPS Growth 5YA 3.33% for the company 16.84 for the sector
5 Year Sales Growth 5YA 11.88% for the company 12.01 for the sector
Dividend Yield ANN 2.15% for the company 1.37 for the sector
Final view
After reviewing the company file, we express our opinion as
the assets are continuously increasing so the net income, free cash flow which is a good sign
by looking at the 5-year ratios we see the company is growing
The dividend ratio is perfect for the shareholders who own the shares for long-term investment.
the total debt is fine we can see it increasing but in the long run, I believe It will not be a problem for the company.
the company performance Improved with the spread of the pandemic, still, I think the pandemic will increase in the coming period
as we see omicron news.
CVS is a good buy now
11/21/21 CVSCVS Health Corporation ( NYSE:CVS )
Sector: Retail Trade (Drugstore Chains)
Current Price: $93.16
Breakout price trigger: $95.70
Buy Zone (Top/Bottom Range): $92.00-$89.00
Price Target: $100.40-$102.00
Estimated Duration to Target: 53-57d
Contract of Interest: $CVS 1/21/21 95c, $CVS 1/21/22 100c
Trade price as of publish date: $2.55/contract, $1.08/contract
HTF - Long CVSCVS really likes testing this rising, upper trend line. It's reversed every time it has crossed it, but it keeps coming back for more. We seem to be heading back now, as an inverse head and shoulders appears to be forming, and it's on the verge of breaking out of it's local trend line, while starting to curve upwards. MACD supports a reversal here. RSI supports continued upwards momentum. Price has made a lower low and a new local higher high. Be warned... the trend line we're touching right now could also act as short term resistance. Another lower low would be healthy.
This appears to be a good long term play. Looks like it is possible of reaching 174 by 2024.